Evidence map›Paper›PMID 23358884›Full record

Trial reportJAMA neurology2013

Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women.

Rosebud O Roberts, Yonas E Geda, David S Knopman, Ruth H Cha, V Shane Pankratz, Bradley F Boeve, Eric G Tangalos, Robert J Ivnik, Michelle M Mielke, Ronald C Petersen

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Multimorbidity measures associated with cognitive function among community-dwelling older Chinese adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients.International journal of environmental research and public health · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cognitive dysfunction in atrial fibrillation.Nature reviews. Cardiology · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Atrial fibrillation, cognitive impairment, and neuroimaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016
    Article
  20. Multimorbidity and Risk of Mild Cognitive Impairment.Journal of the American Geriatrics Society · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rosebud O RobertsDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. roberts.rosebud@mayo.edu
Yonas E Geda
David S Knopman
Ruth H Cha
V Shane Pankratz
Bradley F Boeve
Eric G Tangalos
Robert J Ivnik
Michelle M Mielke
Ronald C Petersen
Department of Medical Sciences · BYMayo Clinic · USMayo Clinic in Arizona · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Ethics of Surrogate Consent for Dementia ResearchR01AG029550 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, SCOTT Y · 2007 to 2010
$1.6M
Psychiatric Characterization/Mild Cognitive ImpairmentK01MH068351 · NIMH · MAYO CLINIC ROCHESTER · PI GEDA, YONAS E · 2004 to 2008
$890k
Vascular /Inflammatory Predictors of MCI Risk /ProgressiK01AG028573 · NIA · MAYO CLINIC ROCHESTER · PI ROBERTS, ROSEBUD O · 2006 to 2008
$351k
NIA NIH HHS K01 AG028573NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG029550NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG034676NIA NIH HHS U01 AG006786NIA NIH HHS U01 AG024904NIMH NIH HHS K01 MH068351
6 · The paper itself

Abstract

objectiveTo investigate the association of cardiac disease with amnestic and nonamnestic mild cognitive impairment (aMCI and naMCI, respectively). Nonamnestic mild cognitive impairment, a putative precursor of vascular and other non-Alzheimer dementias, is hypothesized to have a vascular etiology.

designA prospective, population-based, cohort study with a median 4.0 years of follow-up.

settingOlmsted County, Minnesota.

participantsA total of 2719 participants were evaluated at baseline and every 15 months using the Clinical Dementia Rating scale, a neurological evaluation, and neuropsychological testing. A diagnosis of normal cognition, MCI, or dementia was made by consensus. Cardiac disease at baseline was assessed from the participant's medical records.

main outcome measuresIncident MCI, aMCI, or naMCI.

resultsOf 1450 participants without MCI or dementia at baseline, 366 developed MCI. Cardiac disease was associated with an increased risk of naMCI (hazard ratio, 1.77 [95% CI, 1.16-2.72]). However, the association varied by sex (P = .02 for interaction). Cardiac disease was associated with an increased risk of naMCI (hazard ratio, 3.07 [95% CI, 1.58-5.99]) for women but not for men (hazard ratio, 1.16 [95% CI, 0.68-1.99]). Cardiac disease was not associated with any type of MCI or with aMCI.

conclusionsCardiac disease is an independent risk factor for naMCI; within-sex comparisons showed a stronger association for women. Prevention and management of cardiac disease and vascular risk factors may reduce the risk of naMCI.

Indexed as

AmnesiaAgedAged, 80 and overCognition DisordersCohort StudiesFemaleFollow-Up StudiesHeart DiseasesHumansLongitudinal StudiesMalePopulation SurveillanceProspective StudiesRisk FactorsSex Factors

Identifiers

PMID23358884
PMCPMC3734560
OpenAlexW2019539642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.